Boele, Florien W.
Weimer, Jason M.
Marsland, Anna L.
Armstrong, Terri S.
Given, Charles W.
Drappatz, Jan
Donovan, Heidi S.
Sherwood, Paula R.
Funding for this research was provided by:
National Institute of Nursing Research (R01 NR013170)
Yorkshire Cancer Research (L389FB)
Article History
Received: 11 May 2021
Accepted: 30 August 2021
First Online: 16 October 2021
Change Date: 24 May 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00520-022-07146-8
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: All participants provided written informed consent.
: All participants provided consent for publication.
: Jan Drappatz: equity from Gilead and Pfizer, consulting fees from Agios. Judith Proudfoot: involved in development of Beating the Blues, and consultancy to the company formerly distributing the program. All other authors declare no competing interests.